Site brasileiro onde você pode comprar qualidade e entrega http://farmaciabrasilrx.com/ cialis barato em todo o mundo.

Three.myconference.co.za

APSSA / SAAPI
Friday, 4 October 2013
07h00-10h00
TEA & REGISTRATION
JOPENING AND WELCOME JOINT SESSION : CHAIR Prof Sarel Malan
o
i
10h00-10h15
Opening and introduction of Minister of Health Prof Sarel Malan (UWC)
Theuns Botha (Minister of Health, Western Cape)
S11h00-11h30 Key challenges faced in each sector
ICPA-Sham Moodley : Academy-Dr Shirley-Anne Boschmans : SAAPI-Robyn Daniel
Mr Scott Senwelo (Past President Botswana Pharmaceutical Society)
International Non-Proprietary Names (INN) Programme Dr Raffaella Balocco - WHO
i12h50-13h00 Q&A
13h00-14h30
Opening of Exhibition & Lunch
ACADEMIC SESSION 1: Nanoscience, Drug Design &
ADHERENCE SESSIONS : CHAIR Sham Moodley
Discovery CHAIR: Prof S van Dyk
Per Troein - IMS
14h30-15h00 Drug carriers and particulate drug delivery Prof V Torchilin
The influence of C5 and C6 substitution on the Per Troein - IMS
monoamine oxidase B inhibitory activity of Dr M van der Walt
Eco-friendly and cost-effective, synthesis Using motivational interviews in adherence Prof Angeni Bheekie
15h20-15h40 processes for potential active pharmaceutical Dr B Samant
An insight into diverse computational methods pharmaceutical application for Deaf users and Mrs M Parker
Ms S Moonsamy
In Silico Quantitation of the Molecular Energy Ms L du Toit / Prof
16h00-16h30 and Surface Attributes of Multi-Modal 16h30-17h00
Tea in Exhibition Centre
ACADEMIC SESSION 2: Pharmacy Education
BUSINESS OF PHARMACY : CHAIR Verity Izeboud
CHAIR: Dr S Burton
B17h00-17h25 Value of Pharmacy Data
Ms Linda Reid-IMS
Dr J Joubert
Ms Lullu Krugel-KPMG 17h20-17h40 Factors in flipping the pharmacology classroom
Interdisciplinary Learning: Joint Patient 17h40-18h00 Encounters with Undergraduate Medical and Mrs D Johnston
19h00-22h00
Dinner in Exhibition Center - Platinum Sponsor speech
Saturday, 5 October 2013
ACADEMIC SESSION 3: Natural Products CHAIR:
NATIONAL HEALTH INSURANCE : CHAIR Solly Suleman
Dr I Vermaak
Breakfast session on Hypertension: Sponsored by Prof Bryan Rayner
Biogaran. ACT TODAY……. For tomorrow.
t08h55-09h00 Welcome and Speaker Intro
Solly Suleman
Prof M Heinrich
Prof M Davies-
09h20-09h50 Marine drug discovery in South Africa SASBCP AGM
Challenges in quality control of herbal medicines - Prof A Viljoen
Prof Nadine Butler
Assessing equity in the distribution of community Modelling of flavonoid glycoside dissolution from pharmacies in preparation for the NHI: Role of Ms O Mbamalu
Dr Kim Ward
different Sutherlandia frutescens materials independent community pharmacy and public clinics.
Metropolitan Clinics in Independent Community Rene Anderson-MHG
10h30-10h35 Intro to tea poster presentation Prof N Butler
10h30-11h00
TEA & POSTER PRESENTATION
YOUNG SCIENTISTS SESSION 1 CHAIR:
ACADEMIC SESSION 4: Therapeutics
REMUNERATION : CHAIR: Elze Rossouw
Dr K Obikeze
CHAIR: Prof T Brink
A rapid and reproducible HPLC method for the 11h00-11h15 quantification of fucoxanthin from marine brown Mr B Mubaiwa
Jackie Maimin
The antioxidant properties of bufadienolides 11h15-11h30 analogous to the orbicusides of Cotyledon Ms J Aucamp
Prof D Oliver
Ms S Mostert
[(phenylethyl)sulfanyl]caffeine analogues Ethical Responsibility vs Funding Control Andy Gray - FIP
Novel aminoquinoline-polycyclic molecules as 11h45-12h00 potential antimalaria agents against Plasmodium Mr E Fortuin
An in vitro multi-parametric assessment of the Monoamine oxidase inhibitory activities of Mrs C Minders
hepatotoxic effects of Acokanthera oppositifolia Mr W Cordier
Dr Inez Naidu-DH
Amos Masango-SAPC
Antidepressant properties of azure B and a Mrs A Delport
Services. A debate between SAPC, Discovery Johan Raats-PCDT
An assessment of factors influencing adolescent -12h00-13h00 Health, Gems, Metropolitan and PCDT
Zohra Mahomed-MHG
12h30-12h45 pregnancy in two rural Eastern Cape Ms A Siruma
Pharmacists with Dr Kruger. Chaired by Andy GEMS, Dr Johann
HER-2 positive breast cancer: Which cytotoxic Kruger- President
Assessment of potential drug-drug interactions agent best compliments Trastuzumab's efficacy Miss T Hurrell
12h45-13h00 among South African children and adolescents Mr C Van Rooyen
13h00-14h00
JOINT SESSION
J14h00-14h30 Advances in Treatment of Epilepsy
Prof Barry Gidal
Future of Pharmacovigilance in South Africa Prof Banoo
n15h0015h10
15h10-15h30
TEA & POSTER PRESENTATION
YOUNG SCIENTISTS SESSION 2
SASBCP YOUNG SCIENTIST
BEST PEER PRACTICES : CHAIR Mogologolo Phasha
CHAIR: Mr N Ebrahim
CHAIR: Mr S Amod
Cost Comparison between Repackaging Bulk OralSolid Medicines and Manufacturer-Prepared Johan Raats
15h30-15h45 Patient-Ready Packs in the Public Sector in South Mr A Abahamye
Pharmacokinetics of para-aminosalicylic acid Work-related basic need satisfaction of pharmacy Ms C Coetzer
given once or twice daily to adult MDR/XDR TB Ms L de Kock
Tiny van Schalkwyk &
Brian Thomas
The synthesis and evaluation of quinolinone Ms L Meiring
derivatives as inhibitors of monoamine oxidase In vitro drug screening of potential novel Haldane Murray, Tiny
Novel tricycloundecane derivatives as potential N- Insuring your valuables- Assets and Staff Mr A Egunlusi
Ms D Steyn
& Warren Dean
channel inhibitors for neuroprotection.
Synthesis of 3, 4-dihydropyrimidine-2(1H)-ones The effect of early-life exposure of rats to 16h30-16h45 and -imines as adenosine A1 and A2A Ms R Katsidzera
Venlafaxine on behaviour and neurobiological Mr R Kruger
markers of antidepressant action in adulthood Gary Hendrickse
Synthesis of naphthoquinone derivatives as The kinetic evaluation of the inhibitory potential potential anti-trypanosomal agents against of a polyherbal tea mixture and its constituents Ms C Chakaingesu
Mrs V Paddy
Synthesis of polycyclic non-steroidal anti- inflammatory prodrugs and their biological Prescribing error in three adult wards at a 17h00-17h15 evaluation as potential therapeutic agents in Ms M Abaniwonda
Mr M Vally
Design, synthesis and biological evaluation of 2- 17h15-17h30 aminopyrimidines as dual adenosine A1 and A2A Ms J Kleynhans
ACADEMIC SESSION 5
Factors affecting adherence rates to highly active Development and assessment of captopril loaded antiretroviral therapy among patients attending Dr NL Katende-
Ms S Mukozhiwa
a public health care facility in Mthatha, Eastern Inflammation as a contributing factor in the Mr P Makoni
Development and evaluation of efavirenz-loaded pathophysiology of schizophrenia: pre-clinical Dr M Möller
19h00-22h00
Evening function
Sunday, 6 October 2013
08h00-09h00
Kobus le Roux
08h00-09h00
APSSA AGM
JOINT SESSION
J09h00-09h15 Address and Launch of Adherence Institute.
Mr Sham Moodley
Awards Ceremony -Academy Oath Taking Ceremony Dr Shirley-Anne Boschmans / Prof Nadine Butler
n09h45-10h15 Developing medicines for emerging markets
Dr Dushen Chetty (GSK)
Dominique Jordan - President CPS FIP Foundation
e11h00-11h15 Thank you to exhibitors/sponsors
Kobus le Roux
11h15-11h45
WORKSHOPS & PRACTICAL SESSIONS
WORKSHOP 1
WORKSHOP 2
WORKSHOP 3
WORKSHOP 4
WORKSHOP 5
Pharmacovigilan
Asthma Management (Assessing the Asthma Preparing a Paper for Frail Care Opportunities in Community Pharmacy
Motivational Interviews in Adherence by ce Awareness
Patient, Clinical Measurements, Treatment
Publication by (Incontinence, Wound Care, Chronic Meds) by
Prof Angeni Bheekie, Dr Mea van Huyssteen, Prof Nadine
within your daily
Guidelines) by Dr
Prof Michael Heinrich
Sister Anne Berzen. Sponsored by Smith & Nephew.
environment by
Shaunagh Emanual
Aadila Patel
o
p
s13h15-14h30

LUNCH AND DEPARTURE

Source: http://www.three.myconference.co.za/Programme_23_sept_2013.pdf

somnisdesperts.net

Educant la consciència, actuant en conseqüència TRES ARTICLES DE BA JIN (LI PEI KAN) SOBRE ELS PROBLEMES DE L’ANARQUISME I LA REVOLUCIÓ XINESA Vera Z19/07/2008www.alasbarricadas.orgTraducció al castellà de José Antonio Gutiérrez DantonExtret de: anarkismo.net Li Pei Kan (Ba Jin) al 1928 Els següents tres articles, disponibles per primera vegada en castellà, han estat es

friendswithms.com

The new immune system medications provide true disease man-agement for the first time. They clearly are not for everyone withMS and must be selected and used with expert advice. The back-bone to MS management has been and continues to be the man-agement of symptoms. Everyone with MS should be aware of themany ways that the symptoms of MS can be managed, with the goalof improved quality of life. S

Copyright © 2010-2014 Articles Finder